46 completed. 46 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 46 | Completed 46 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Swift Microwave Device for Onychomycosis Swift Microwave treatment - weekly x 4wks, Swift Microwave treatment - Every other week x 4wks, Swift Microwave treatment - Every other week x 24wks - Onychomycosis of Toenail | Phase 1 / Phase 2 | Completed | Mediprobe Research Inc. | 39 | 2023-03-27 | 2024-11-18 |
| A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail BB2603-1, BB2603-3, BB2603-10 - Distal Subungual Onychomycosis, Fungal Infection | Phase 2 | Completed | Blueberry Therapeutics | 111 | 2021-03-22 | 2023-08-01 |
| A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis UHE-103A1 cream, UHE-103A2 cream, UHE-103B cream - Tinea Pedis | Phase 2 | Completed | Therapeutics, Inc. | 240 | 2019-03-15 | 2021-10-28 |
| A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis Janthinobacterium lividum - Tinea Pedis | Phase 2 | Completed | DermBiont, Inc. | 12 | 2019-02-19 | 2025-06-17 |
| Three-Arm Trial of Novel Treatment for Tinea Pedis Experimental Drug SESC 01, Placebo, Terbinafine Hydrochloride - Tinea Pedis | Phase 2 | Completed | South End Skin Care | 90 | 2017-01-03 | 2017-10-06 |
| Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot Nitric Oxide, Water - Tinea Pedis | Phase 2 | Completed | Nitric Solutions Inc. | 20 | 2016-08-13 | 2019-09-20 |
| SB208 for the Treatment of Tinea Pedis SB208 2%, SB208 4%, SB208 16% - Tinea Pedis | Phase 2 | Completed | Novan, Inc. | 222 | 2016-07-19 | 2019-01-10 |
| Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail HTS-519 Insert - Onychomycosis | Phase 2 | Completed | Hallux, Inc. | 30 | 2016-07-01 | 2021-11-02 |
| Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study NVXT topical, Placebo (Vehicle) Topical - Onychomycosis | Phase 2 | Completed | Sun Pharmaceutical Industries, Inc. | 184 | 2016-03-21 | 2018-12-20 |
| Design and Clinical Evaluation of a School Meal With Deworming Properties Ujiplus, Albendazole, uji - Helminthiasis, Tinea Capitis | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 326 | 2015-05-01 | 2016-09-07 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail VT-1161, Placebo - Onychomycosis | Phase 2 | Completed | Viamet | 259 | 2015-02-17 | 2020-11-04 |
| Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail. PD P 506 A - Onychomycosis | Phase 2 | Completed | photonamic GmbH & Co. KG | 25 | 2015-01-01 | 2017-09-19 |
| Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail NVXT Solution, Vehicle of test product - Onychomycosis | Phase 2 | Completed | Sun Pharmaceutical Industries, Inc. | 47 | 2014-12-01 | 2018-09-19 |
| Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis Dapaconazole, Ketoconazole - Tinea Pedis | Phase 2 | Completed | Gilberto De Nucci | 60 | 2014-07-01 | 2016-07-07 |
| Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris Dapaconazole, Miconazole Nitrate - Tinea Cruris | Phase 2 | Completed | Galeno Desenvolvimento de Pesquisas Clínicas | 51 | 2014-01-29 | 2017-12-02 |
| Efficacy and Safety Study of ME1111 in Patients With Onychomycosis ME1111 Solution, Low strength, ME1111 Solution, High strength, Matching Vehicle Solution - Onychomycosis | Phase 2 | Completed | Meiji Seika Pharma Co., Ltd. | 304 | 2013-12-19 | 2024-03-18 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis VT-1161, placebo - Tinea Pedis | Phase 2 | Completed | Viamet | 50 | 2013-08-01 | 2018-08-01 |
| Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai kandhaga rasayanam - Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied | Phase 2 | Completed | National institute of Siddha | 50 | 2012-06-01 | 2014-09-12 |
| Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis Luliconazole Solution, 10%, Vehicle Solution - Distal and Lateral Subungual Onychomycosis | Phase 2 / Phase 3 | Completed | Topica Pharmaceuticals | 334 | 2012-05-01 | 2015-11-30 |
| Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail Terbinafine HCl - Onychomycosis | Phase 2 | Completed | Nitric BioTherapeutics, Inc | 25 | 2011-12-01 | 2012-10-19 |
Showing 20 of 46. Sign in to see all of them.
Onychomycosis (30) · Tinea Pedis (13) · Mycoses (3) · Tinea Cruris (2) · Anemia (1) · Communicable Diseases (1) · Dermatomycoses (1) · Foot Dermatoses (1) · Foot Diseases (1) · Helminthiasis (1) · Infections (1) · Pruritus (1) · Skin Diseases (1) · Tinea Capitis (1)
Bacterial Infections and Mycoses (46) · Skin Diseases, Infectious (46) · Skin and Connective Tissue Diseases (46) · Dermatomycoses (45) · Infections (45) · Skin Diseases (45) · Mycoses (43) · Nail Diseases (30) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (13) · Skin Manifestations (13) · Foot Dermatoses (12) · Foot Diseases (12) · Pruritus (12)
Terbinafine (5) · tavaborole (5) · 1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (2) · Nitric Oxide (2) · VT-1161 (2) · Albendazole (1) · Econazole (1) · Exercise (1) · Itraconazole (1) · Ketoconazole (1) · Miconazole (1) · Nitrogen (1) · Oxygen (1) · Separase (1) · Water (1)
Pfizer (7) · Nitric BioTherapeutics, Inc (4) · Sun Pharmaceutical Industries, Inc. (2) · Topica Pharmaceuticals (2) · Viamet (2) · Abeona Therapeutics, Inc (1) · Almirall, S.A. (1) · AmDerma (1) · Bayer (1) · Blueberry Therapeutics (1) · Celtic Pharma Development Services (1) · DermBiont, Inc. (1) · Dow Pharmaceutical Sciences (1) · Galeno Desenvolvimento de Pesquisas Clínicas (1) · Gilberto De Nucci (1)
United States (24) · Canada (8) · Germany (4) · Mexico (4) · Dominican Republic (2) · Brazil (1) · Czechia (1) · Iceland (1) · India (1) · Poland (1) · Puerto Rico (1) · Saint Kitts and Nevis (1) · Sweden (1)
Aditya Gupta, MD,PhD (1) · Alicia Barba, MD (1) · Alicia Bucko, DO (1) · Bernard Goffe, MD (1) · Boni Elewski, MD (1) · Brock McConnehey,, DO (1) · Carl Schanbacher, MD (1) · Charles Lynde, MD (1) · Christoph Willers, MD, MBA (1) · Dan Stewart, DO (1) · Daniel G. Lorch, MD (1) · David Bolshoun, MD (1)
PMID 21967490, PMID 23377392, PMID 30526582, PMID 32421854, PMID 39624747
2008 (1), 2009 (1)